688389 普门科技
已收盘 09-30 15:00:00
资讯
新帖
简况
普门科技:控股子公司取得光子治疗仪医疗器械注册证
格隆汇 · 09-29 16:57
普门科技:控股子公司取得光子治疗仪医疗器械注册证
普门科技(688389)披露公司产品获得欧盟MDR认证,9月22日股价上涨1.09%
证券之星 · 09-22
普门科技(688389)披露公司产品获得欧盟MDR认证,9月22日股价上涨1.09%
普门科技:电化学发光物质已实现自研自产
证券之星 · 09-16
普门科技:电化学发光物质已实现自研自产
普门科技:采用多产品、多市场平台型发展模式
证券之星 · 09-16
普门科技:采用多产品、多市场平台型发展模式
普门科技:公司基于射频技术平台的射频治疗仪处于正常研发进展中
证券之星 · 09-16
普门科技:公司基于射频技术平台的射频治疗仪处于正常研发进展中
股市必读:普门科技新发布《深圳普门科技股份有限公司高级管理人员减持股份结果公告》
证券之星 · 09-07
股市必读:普门科技新发布《深圳普门科技股份有限公司高级管理人员减持股份结果公告》
股市必读:普门科技新发布《深圳普门科技股份有限公司高级管理人员减持股份结果公告》
证券之星 · 09-04
股市必读:普门科技新发布《深圳普门科技股份有限公司高级管理人员减持股份结果公告》
普门科技:9月1日高级管理人员邱亮减持股份合计6万股
证券之星 · 09-01
普门科技:9月1日高级管理人员邱亮减持股份合计6万股
每周股票复盘:普门科技(688389)高管减持3万股
证券之星 · 08-30
每周股票复盘:普门科技(688389)高管减持3万股
普门科技:8月28日董事邱亮减持股份合计3万股
证券之星 · 08-28
普门科技:8月28日董事邱亮减持股份合计3万股
股市必读:普门科技(688389)8月26日披露最新机构调研信息
证券之星 · 08-27
股市必读:普门科技(688389)8月26日披露最新机构调研信息
普门科技(688389)披露2026年半年度报告,8月24日股价下跌3.23%
证券之星 · 08-24
普门科技(688389)披露2026年半年度报告,8月24日股价下跌3.23%
股市必读:普门科技中报 - 第二季度单季净利润同比下降31.08%
证券之星 · 08-24
股市必读:普门科技中报 - 第二季度单季净利润同比下降31.08%
普门科技(688389)2026年中报简析:增收不增利,三费占比上升明显
证券之星 · 08-23
普门科技(688389)2026年中报简析:增收不增利,三费占比上升明显
每周股票复盘:普门科技(688389)Q2净利降31.08%
证券之星 · 08-23
每周股票复盘:普门科技(688389)Q2净利降31.08%
普门科技(688389)6月30日股东户数1.1万户,较上期减少3.01%
证券之星 · 08-22
普门科技(688389)6月30日股东户数1.1万户,较上期减少3.01%
图解普门科技中报:第二季度单季净利润同比下降31.08%
证券之星 · 08-22
图解普门科技中报:第二季度单季净利润同比下降31.08%
普门科技(688389)披露2026年半年度业绩说明会公告,8月20日股价上涨4.1%
证券之星 · 08-20
普门科技(688389)披露2026年半年度业绩说明会公告,8月20日股价上涨4.1%
股市必读:普门科技(688389)8月5日董秘有最新回复
证券之星 · 08-06
股市必读:普门科技(688389)8月5日董秘有最新回复
普门科技:公司暂无此研发计划
证券之星 · 08-05
普门科技:公司暂无此研发计划
加载更多
公司概况
公司名称:
深圳普门科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2019-11-05
主营业务:
深圳普门科技股份有限公司的主营业务是医疗器械的研发、制造、营销及服务。公司的主要产品是光子治疗仪、红外治疗仪、空气波压力治疗系统、高频振动排痰系统、特定蛋白分析仪、糖化血红蛋白分析仪、电化学发光免疫分析仪、配套检测试剂。公司的“特定蛋白分析仪产业化项目”获得“2018年度深圳市科技进步奖一等奖”,系列产品已获国内顶级医院认可。
发行价格:
9.10
{"stockData":{"symbol":"688389","market":"SH","secType":"STK","nameCN":"普门科技","latestPrice":11.38,"timestamp":1790751600000,"preClose":11.26,"halted":0,"volume":2637463,"delay":0,"changeRate":0.0107,"floatShares":428000000,"shares":428000000,"eps":0.3313,"marketStatus":"已收盘","change":0.12,"latestTime":"09-30 15:00:00","open":11.3,"high":11.47,"low":11.25,"amount":29999900,"amplitude":0.0195,"askPrice":11.38,"askSize":5,"bidPrice":11.37,"bidSize":261,"shortable":0,"etf":0,"ttmEps":0.3313,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":11.26,"symbolType":"stock_kcb","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":12.39,"lowLimit":10.13,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":428485730,"isCdr":false,"pbRate":2.35,"roa":"--","peRate":34.349532,"roe":"3.71%","epsLYR":0.43,"committee":-0.55846,"marketValue":4876000000,"turnoverRate":0.0062,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-10-08。","afterMarket":{"amount":0,"volume":0,"close":11.38,"buyVolume":1000,"sellVolume":0,"time":1790753637746,"indexStatus":"已收盘 09-30 15:30:00","preClose":11.26},"floatMarketCap":4876000000},"requestUrl":"/m/hq/s/688389","defaultTab":"news","newsList":[{"id":"2671297322","title":"普门科技:控股子公司取得光子治疗仪医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2671297322","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671297322?lang=zh_cn&edition=full","pubTime":"2026-09-29 16:57","pubTimestamp":1790672274,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0251","159883","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669614806","title":"普门科技(688389)披露公司产品获得欧盟MDR认证,9月22日股价上涨1.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669614806","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669614806?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:49","pubTimestamp":1790070556,"startTime":"0","endTime":"0","summary":"截至2026年9月22日收盘,普门科技报收于11.13元,较前一交易日上涨1.09%,最新总市值为47.69亿元。近日,深圳普门科技股份有限公司发布关于自愿披露公司产品获得欧盟MDR认证的公告。公告显示,公司近期获得欧盟MDR认证证书,证书编号G15 099663 0015 Rev.00,签批时间为2026年9月16日,有效期至2028年10月16日。上述产品通过CE认证,符合欧盟最新医疗器械法规要求,具备在欧盟市场销售的准入条件,有助于推动相关产品的海外推广与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200031436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["FESXmain","688389","BK0251","FSXEmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667865605","title":"普门科技:电化学发光物质已实现自研自产","url":"https://stock-news.laohu8.com/highlight/detail?id=2667865605","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667865605?lang=zh_cn&edition=full","pubTime":"2026-09-16 15:34","pubTimestamp":1789544063,"startTime":"0","endTime":"0","summary":"证券之星消息,普门科技(688389)09月16日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司在近三年,诊断试剂的自产率到多少了?抗体抗原以及核心原材料目前能不能做到完全自产?谢谢!普门科技回复:在电化学发光试剂方面,核心原料电化学发光物质已实现自研自产,抗原抗体是与核心供应商合作研发;在糖化血红蛋白试剂方面,色谱填料与层析柱均已实现100%自产,质控品、校准品亦100%自产;在特定蛋白试剂方面,核心原料胶乳微球已完全实现自主生产,其他原料正在积极规划中。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600019464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688389","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667605871","title":"普门科技:采用多产品、多市场平台型发展模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2667605871","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667605871?lang=zh_cn&edition=full","pubTime":"2026-09-16 15:34","pubTimestamp":1789544063,"startTime":"0","endTime":"0","summary":"证券之星消息,普门科技(688389)09月16日在投资者关系平台上答复投资者关心的问题。投资者提问:今年迈瑞开始加大急诊的开发,公司是否面临较大的竞争压力?有何应对措施?谢谢!普门科技回复:尊敬的投资者,您好!公司采用多产品、多市场的平台型公司发展模式,让公司能够更好地抵御市场不确定性风险。依托多年来的技术沉淀和渠道资源积累,公司坚持在体外诊断、临床医疗、皮肤医美和消费者健康四大业务板块进行拓展,形成独特的竞争优势,可以支撑公司未来中长期的持续稳定成长。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600019466.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667605833","title":"普门科技:公司基于射频技术平台的射频治疗仪处于正常研发进展中","url":"https://stock-news.laohu8.com/highlight/detail?id=2667605833","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667605833?lang=zh_cn&edition=full","pubTime":"2026-09-16 15:34","pubTimestamp":1789544063,"startTime":"0","endTime":"0","summary":"证券之星消息,普门科技(688389)09月16日在投资者关系平台上答复投资者关心的问题。投资者提问:公司半年报有一句“ 射频微针类产品已进入注册阶段,射频治疗仪产品亦在正常研发进展中”。请问这句话怎么理解?射频微针不就是射频治疗仪吗?难道两者是不同的产品吗?谢谢!普门科技回复:尊敬的投资者,您好!公司基于射频技术平台的射频治疗仪处于正常研发进展中。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600019460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665362077","title":"股市必读:普门科技新发布《深圳普门科技股份有限公司高级管理人员减持股份结果公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2665362077","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665362077?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:28","pubTimestamp":1788715690,"startTime":"0","endTime":"0","summary":"公司公告汇总深圳普门科技股份有限公司高级管理人员减持股份结果公告邱亮减持前持有公司股份4,090,385股;截至2026年9月2日减持期届满,通过集中竞价方式累计减持90,000股,减持价格区间为11.05至11.30元/股,合计金额1,003,350元;减持后持股数量为4,000,385股,持股比例为0.93%;原计划减持910,000股,本次未完成;减持行为符合披露计划,未违反相关法规及承诺。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688389","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664806419","title":"股市必读:普门科技新发布《深圳普门科技股份有限公司高级管理人员减持股份结果公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664806419","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664806419?lang=zh_cn&edition=full","pubTime":"2026-09-04 02:22","pubTimestamp":1788459733,"startTime":"0","endTime":"0","summary":"公司公告汇总深圳普门科技股份有限公司高级管理人员减持股份结果公告副总经理邱亮本次减持计划实施前持有公司股份4,090,385股;截至2026年9月2日减持时间区间届满,通过集中竞价方式累计减持90,000股,减持价格区间为11.05至11.30元/股,合计金额1,003,350元;减持后持股数量为4,000,385股,持股比例为0.93%;原计划拟减持910,000股,本次未完成;减持行为符合披露计划,未违反相关法规及承诺。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400002625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664856424","title":"普门科技:9月1日高级管理人员邱亮减持股份合计6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664856424","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664856424?lang=zh_cn&edition=full","pubTime":"2026-09-01 20:01","pubTimestamp":1788264078,"startTime":"0","endTime":"0","summary":"证券之星消息,根据9月1日市场公开信息、上市公司公告及交易所披露数据整理,普门科技最新董监高及相关人员股份变动情况:2026年9月1日公司高级管理人员邱亮共减持公司股份6.0万股,占公司总股本为0.014%。普门科技近半年内的董监高及核心技术人员增减持详情如下:普门科技的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出128.03万,融资余额减少;融券净流入975.0,融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100038139.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663045327","title":"每周股票复盘:普门科技(688389)高管减持3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663045327","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663045327?lang=zh_cn&edition=full","pubTime":"2026-08-30 09:19","pubTimestamp":1788052748,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,普门科技报收于10.99元,较上周的11.16元下跌1.52%。本周,普门科技8月24日盘中最高价报11.2元。普门科技当前最新总市值47.09亿元,在医疗器械板块市值排名73/129,在两市A股市值排名3345/5211。来自机构调研要点:公司2026年上半年整体毛利率为63.22%,同比下降1.47个百分点。股本股东变化高管增减持2026年8月28日,公司董事邱亮减持3.0万股,占公司总股本0.007%。当日公司股价下跌0.27%,收盘价为10.99元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662235060","title":"普门科技:8月28日董事邱亮减持股份合计3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662235060","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662235060?lang=zh_cn&edition=full","pubTime":"2026-08-28 20:01","pubTimestamp":1787918476,"startTime":"0","endTime":"0","summary":"证券之星消息,根据8月28日市场公开信息、上市公司公告及交易所披露数据整理,普门科技最新董监高及相关人员股份变动情况:2026年8月28日公司董事邱亮共减持公司股份3.0万股,占公司总股本为0.007%。普门科技近半年内的董监高及核心技术人员增减持详情如下:普门科技的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流入150.85万,融资余额增加;融券净流入1.09万,融券余额增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800048599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662966728","title":"股市必读:普门科技(688389)8月26日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2662966728","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662966728?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:43","pubTimestamp":1787784200,"startTime":"0","endTime":"0","summary":"截至2026年8月26日收盘,普门科技报收于11.03元,上涨0.55%,换手率0.4%,成交量1.72万手,成交额1897.35万元。当日关注点交易信息汇总:8月26日主力资金净流入191.38万元,占总成交额10.09%。机构调研要点:国家医保局《检验类医疗服务价格项目立项指南(试行)》发布,试点省份将于2026年启动落地,全国范围预计2027年全面开展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700013184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661433220","title":"普门科技(688389)披露2026年半年度报告,8月24日股价下跌3.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661433220","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661433220?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:18","pubTimestamp":1787566734,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘,普门科技报收于10.8元,较前一交易日下跌3.23%,最新总市值为46.28亿元。近日,普门科技披露《2026年半年度报告》。本报告期实现营业收入603,907,940.52元,同比增长19.15%;利润总额为80,889,428.25元,同比下降32.11%;归属于上市公司股东的净利润为79,273,514.44元,同比下降34.80%;扣除非经常性损益后的净利润为76,782,414.26元,同比下降30.80%。研发投入占营业收入的比例为20.23%,较上年同期下降2.04个百分点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400026212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661498602","title":"股市必读:普门科技中报 - 第二季度单季净利润同比下降31.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661498602","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661498602?lang=zh_cn&edition=full","pubTime":"2026-08-24 06:40","pubTimestamp":1787524818,"startTime":"0","endTime":"0","summary":"业绩披露要点:2026年上半年归母净利润7927.35万元,同比下降34.8%;第二季度单季度归母净利润4678.94万元,同比下降31.08%。深圳普门科技股份有限公司2026年半年度报告摘要截至报告期末,公司总资产为2,618,577,846.56元,较上年度末下降6.80%;归属于上市公司股东的净资产为2,077,695,878.39元,较上年度末下降1.80%。深圳普门科技股份有限公司2026年度“提质增效重回报”行动方案的半年度评估报告2026年上半年,公司实现营业收入60,390.79万元,归母净利润7,927.35万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400002234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661356212","title":"普门科技(688389)2026年中报简析:增收不增利,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2661356212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661356212?lang=zh_cn&edition=full","pubTime":"2026-08-23 06:07","pubTimestamp":1787436466,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期普门科技发布2026年中报。截至本报告期末,公司营业总收入6.04亿元,同比上升19.15%,归母净利润7927.35万元,同比下降34.8%。本报告期普门科技三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达36.92%。持有普门科技最多的基金为招商核心竞争力混合A,目前规模为10.76亿元,最新净值1.1606,较上一交易日上涨0.06%,近一年下跌9.55%。本文数据来源于普门科技2026年中报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300001670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688389","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661214733","title":"每周股票复盘:普门科技(688389)Q2净利降31.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661214733","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661214733?lang=zh_cn&edition=full","pubTime":"2026-08-23 05:00","pubTimestamp":1787432440,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘,普门科技报收于11.16元,较上周的11.46元下跌2.62%。本周,普门科技8月17日盘中最高价报11.49元。股本股东变化截至2026年6月30日,普门科技股东户数为1.1万户,较3月31日减少340户,减幅3.01%。业绩披露要点普门科技2026年中报显示,上半年主营收入6.04亿元,同比上升19.15%;归母净利润7927.35万元,同比下降34.8%;扣非净利润7678.24万元,同比下降30.8%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300001272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688389","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661216424","title":"普门科技(688389)6月30日股东户数1.1万户,较上期减少3.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661216424","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661216424?lang=zh_cn&edition=full","pubTime":"2026-08-22 17:06","pubTimestamp":1787389595,"startTime":"0","endTime":"0","summary":"证券之星消息,近日普门科技披露,截至2026年6月30日公司股东户数为1.1万户,较3月31日减少340.0户,减幅为3.01%。在医疗器械行业个股中,普门科技股东户数低于行业平均水平,截至6月30日,医疗器械行业平均股东户数为2.15万户。从股价来看,2026年3月31日至2026年6月30日,普门科技区间跌幅为17.84%,在此期间股东户数减少340.0户,减幅为3.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082200014862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661294026","title":"图解普门科技中报:第二季度单季净利润同比下降31.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661294026","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661294026?lang=zh_cn&edition=full","pubTime":"2026-08-22 01:54","pubTimestamp":1787334872,"startTime":"0","endTime":"0","summary":"证券之星消息,普门科技2026年中报显示,上半年度公司主营收入6.04亿元,同比上升19.15%;归母净利润7927.35万元,同比下降34.8%;扣非净利润7678.24万元,同比下降30.8%;其中2026年第二季度,公司单季度主营收入3.44亿元,同比上升17.83%;单季度归母净利润4678.94万元,同比下降31.08%;单季度扣非净利润4502.15万元,同比下降26.2%;负债率21.04%,投资收益17.39万元,财务费用2324.44万元,毛利率63.22%。财报数据概要请见下图:本文数据来源于普门科技2026年中报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082200002061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660238297","title":"普门科技(688389)披露2026年半年度业绩说明会公告,8月20日股价上涨4.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660238297","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660238297?lang=zh_cn&edition=full","pubTime":"2026-08-20 22:35","pubTimestamp":1787236514,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘,普门科技报收于11.42元,较前一交易日上涨4.1%,最新总市值为48.93亿元。该股当日开盘11.04元,最高11.45元,最低11.04元,成交额达4103.06万元,换手率为0.84%。公告显示,公司将于2026年8月28日上午10:00-11:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会,介绍公司半年度经营成果及财务状况。投资者可于8月21日至8月27日16:00前通过上证路演中心网站或公司邮箱提交问题。说明会结束后可通过该平台查看会议内容。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000045668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657524158","title":"股市必读:普门科技(688389)8月5日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2657524158","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657524158?lang=zh_cn&edition=full","pubTime":"2026-08-06 02:23","pubTimestamp":1785954191,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘,普门科技报收于10.97元,上涨0.37%,换手率0.48%,成交量2.07万手,成交额2259.75万元。董秘最新回复投资者: 请问:组织破碎术与重组组织型纤溶酶原激活剂联合应用对深静脉血栓具备溶栓效果,对于此类超声创新技术以及创新应用场景,公司有无研发计划?当日关注点交易信息汇总:8月5日主力资金净流入102.9万元,占总成交额4.55%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688389","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657519527","title":"普门科技:公司暂无此研发计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2657519527","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657519527?lang=zh_cn&edition=full","pubTime":"2026-08-05 15:37","pubTimestamp":1785915437,"startTime":"0","endTime":"0","summary":"证券之星消息,普门科技(688389)08月05日在投资者关系平台上答复投资者关心的问题。投资者提问:请问:组织破碎术(Histotripsy)与重组组织型纤溶酶原激活剂(rt-PA)联合应用对深静脉血栓(DVT)具备溶栓效果,对于此类超声创新技术以及创新应用场景,公司有无研发计划?谢谢!普门科技回复:感谢您的关注,公司暂无此研发计划,谢谢!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500023983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688389","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790911893671,"stockEarnings":[{"period":"1week","weight":0.017},{"period":"1month","weight":0.0308},{"period":"3month","weight":0.0869},{"period":"6month","weight":-0.0448},{"period":"1year","weight":-0.1568},{"period":"ytd","weight":-0.1022}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳普门科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"10955人(较上一季度减少3.01%)","perCapita":"39113股","listingDate":"2019-11-05","address":"广东省深圳市龙华区观湖街道观城社区求知东路8号普门科技总部大厦","registeredCapital":"42848万元","survey":" 深圳普门科技股份有限公司的主营业务是医疗器械的研发、制造、营销及服务。公司的主要产品是光子治疗仪、红外治疗仪、空气波压力治疗系统、高频振动排痰系统、特定蛋白分析仪、糖化血红蛋白分析仪、电化学发光免疫分析仪、配套检测试剂。公司的“特定蛋白分析仪产业化项目”获得“2018年度深圳市科技进步奖一等奖”,系列产品已获国内顶级医院认可。","listedPrice":9.1},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"普门科技(688389)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供普门科技(688389)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"普门科技,688389,普门科技股票,普门科技股票老虎,普门科技股票老虎国际,普门科技行情,普门科技股票行情,普门科技股价,普门科技股市,普门科技股票价格,普门科技股票交易,普门科技股票购买,普门科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"普门科技(688389)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供普门科技(688389)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}